The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
TRODELVY sacituzumab govitecan 180 mg powder for injection vial (353081)
ARTG Name
TRODELVY sacituzumab govitecan 180 mg powder for injection vial
Product name
TRODELVY sacituzumab govitecan 180 mg powder for injection vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
sacituzumab govitecan
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information